Absci launches women's cohort in Phase 1/2a trial of ABS-201 for pattern hair loss

Absci launched a dedicated women's cohort in its Phase 1/2a trial of ABS-201, its AI-developed therapy for pattern hair loss, expanding testing in a market where treatment options for women remain limited.

Detected & updated continuously · Source: Nebula